Filing Flows

Filing Flows › Health Catalyst (HCAT) › How it makes money

How Health Catalyst (HCAT) makes money

Health Catalyst (HCAT) made $56.3M of revenue in the third quarter 2026 (Q3 2026), -26% from a year earlier. Technology brought in $40.7M (72%); Accumulated Impairment Losses brought in $15.6M (28%). Of every dollar of revenue, 89¢ was left as operating profit, 72¢ was left as net earnings.

Drawing the Sankey…

Health Catalyst revenue by segment, Q3 2026Health Catalyst revenue by segment, Q3 2026Technology$40.7MAccumulated Impairment Losses$15.6M
Health Catalyst revenue by quarterHealth Catalyst revenue by quarter$79.4MQ1 2025$80.7MQ2 2025$76.3MQ3 2025$74.7MQ4 2025$70.8MQ1 2026$70.5MQ2 2026$56.3MQ3 2026
Health Catalyst: where each dollar of revenue goesHealth Catalyst: where each dollar of revenue goesOperating profit89¢Net earnings72¢

Revenue by segment, Q3 2026

SegmentRevenueShareQ/QY/Y
Technology$40.7M72.3%-17%-22%
Accumulated Impairment Losses$15.6M27.7%-28%-36%

Where each dollar of revenue goes

LineQ3 2026% of revenue
Revenue$56.3M100.0%
Operating profit$50.1M89.1%
Net earnings$40.5M72.0%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q3 2026$56.3M-26%
Q2 2026$70.5M-13%
Q1 2026$70.8M-11%
Q4 2025$74.7M-6%
Q3 2025$76.3M0%
Q2 2025$80.7M+6%
Q1 2025$79.4M+6%

From Health Catalyst's 10-Q filed Nov 5, 2026 (on EDGAR).

Questions

How does Health Catalyst make money?

Health Catalyst (HCAT) made $56.3M of revenue in the third quarter 2026 (Q3 2026), -26% from a year earlier. Technology brought in $40.7M (72%); Accumulated Impairment Losses brought in $15.6M (28%). Of every dollar of revenue, 89¢ was left as operating profit, 72¢ was left as net earnings.

What is Health Catalyst's biggest business?

Technology: $40.7M in the third quarter 2026, 72% of revenue, -22% from a year earlier.

What is Health Catalyst's profit margin?

Net earnings were $40.5M, 72.0% of revenue, in the third quarter 2026; the operating margin was 89.1%.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.